Master WS-Federation for hybrid identity. Learn how to bridge legacy ASP.NET apps with modern Entra ID and OIDC using the .NET 10 Passive Requestor Profile.

According to MarketsandMarkets™, the Preparative and Process Chromatography Market is projected to grow from about USD 14.32 billion in 2026 to USD 21.50 billion by 2031, at a CAGR of 8.2%. Browse 300 ...

WAAYU, India's pioneering 0% commission food delivery and restaurant technology platform, will host an exclusive NRAI Pune Chapter leadership evening on 24 February 2026 at Veranda, Effingut, Koregaon ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Yashhtej Industries allotment date is likely to be finalised today, February 23. Investors can check Yashhtej Industries IPO allotment status online on BSE and the IPO registrar - MAS Services.

Hinge Health (HNGE) analysis: 2025 growth, strong FCF margins, and a durable AI-resistant moat. Click here to read my most recent analysis of HNGE stock.

DELRAY BEACH, Fla., Feb. 24, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Home Automation System Market is projected to reach USD 80.73 billion by 2032, growing from USD 57.71 billion in ...

Browse 155 market data Tables and 70 Figures spread through 330 Pages and in-depth TOC on "Smart Home Market - Global ...

Certain statements made during this call are forward-looking statements, including those concerning our financial outlook, our market opportunities, and the impact of the global economic environment ...

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Dividend stocks are companies that pay out regular dividends. Dividend stocks are usually well-established companies with a track record of distributing earnings back to shareholders. Understanding ...

The FDA has introduced a new approval process for targeted individualized therapies, including genome editing and RNA-based therapies, intended to treat rare and ultra rare diseases in which ...